Sunday, September 06, 2020 3:48:18 PM
Here are a few things that were happening in the background.
1. GEM gave more money to RLFTF at the end of August.
2. NeuroRx updated the endpoint information in the clinical trials website at the end of August. They deleted some sites that probably have not started recruiting. They did not change completion dates and sample size.
3. Relief hired new CMO on Sep 4th.
4. They remain silence about the trial data.
Why did GEM give RLFTF 32 million at the end of August?
Why did NeuroRx updated the trial information at the end of August?
The interim data must have been very positive and GEM was updated. If negative, do you think GEM will give 32 million to them?
My estimation shows that the interim has been done in/before the week of August 24. This timeline is consistent with what were happening.
If the interim was a blowout, who will they first share with? FDA! That may be why they were so silent, as exciting things are brewing and they do not want anyone to mess it up. Just connect the dots.
Big news is coming.
~ Money Making Money ~
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM